CODA- a device to allow the safe transfer of fluids from the DUET, a retractable safety syringe

针头刺伤（NSI）是指注射器在患者体内意外刺穿另一个人的皮肤，造成血液传播病毒（例如B和C型肝炎以及HIV）的风险。在美国，NHS的NSI成本为5亿英镑和20亿美元。“安全注射器”市场已迅速增长至> 30亿美元，但国家统计局没有显着下降，美国数据显示，大多数发生在使用安全注射器时。C-Major Limited已经证明了DUET的概念，DUET是一种受专利保护的新型安全注射器，它克服了现有注射器的局限性，具有专利可伸缩针头，单手按钮激活和抽吸和注射应用。试验表明安全性显著提高，但强调用于抽吸时仍有发生NSI的风险。因此，本项目的目的是证明CODA的可行性，CODA是一种小型塑料适配器，可在针头缩回后重新打开液路，安全分配任何吸入的液体。带DUET的CODA将通过区域特定经销商销售。最初的目标市场将是A&E单位，护理人员和步行诊所，并扩展到更广泛的医疗应用程序和糖尿病患者。团队：奥布里邓福德，项目经理;西蒙道格拉斯，商务经理;菲利普布朗，技术总监;史蒂夫多布森，运营经理。

A needle-stick injury (NSI) occurs when a syringe that has been in a patient, accidentally punctures another person’s skin posing risk of bloodborne viruses (e.g. Hepatitis B and C and HIV). Cost of NSIs to the NHS is £500m and $2bn in the US. The “safe syringe” market has grown quickly to >$3bn but NSIs are not falling significantly and USA data shows most occur whilst using safe syringes. C-Major Limited has proven the concept of DUET, a novel safety syringe protected by a portfolio of patents which overcomes the limitations of existing syringes with patented retractable needle, one handed push button activation and application in both aspiration & injection. Trials have shown safety is significantly improved, but have highlighted there is still a risk of NSIs when used for aspiration. The objective of this project to therefore prove feasibility of CODA, a small plastic adaptor which enables safe dispensing of any aspirated fluid after retraction of the needle by reopening the fluid path. CODA with DUET will be sold via territory specific distributors. Initial target markets will be A&E units, paramedics and walk in clinics, with expansion into wider medical apps & diabetics. Team: Aubrey Dunford, Project Manager; Simon Douglas, Commercial Manager; Philip Brown, Tech Director; Steve Dobson, Ops Manager.